AstraZeneca Pharma India Ltd.
-
NSE: ASTRAZEN
-
BSE: 506820
-
Q
-
V
-
T
- Expensive Performer
Quality Score
High Financial StrengthValuation Score
Expensive ValuationTechnical Score
Technically NeutralBroker average target upside %
-100.00 %
Negative Broker average target upside %
TTM PE Ratio
111.50
High in industry
Price to Book Ratio
24.90
High in industry
Operating Revenues Qtr Cr
209.48 Cr
Above industry Median
Net Profit Qtr Cr
26.34 Cr
Above industry Median
RSI
20.50
RSI oversold
MFI
8.67
MFI strongly Oversold
MACD
-153.31
MACD below Signal and Center
MACD Signal Line
-80.73
MACD below Signal and Center
30Day SMA Rs
4333.01 Rs
Price below SMA-30
50Day SMA Rs
4389.39 Rs
Price below SMA-50
100Day SMA Rs
4321.40 Rs
Price below SMA-100
200Day SMA Rs
3771.90 Rs
price crossed below SMA200 today
Promoter holding %
75.00
No change in Promoter holding
FII holding current Qtr %
2.36
FII holdings rise by 0.38%
MF holding current Qtr %
1.37
MF holdings fell by 0.85%
Institutions holding %
3.82
Institutions holding decreased by 0.49%.
Broker Average Rating
0.00
Broker Average Rating
Broker Covering stock
0.00
0 Broker Covering stock
Broker 1Year total
0.00
0 Broker 1Year total
Broker 6M Reco downgrade
0.00
0 Broker 6M Reco downgrade
Broker 6M Reco upgrade
0.00
0 Broker 6M Reco upgrade
Broker 6M Target downgrade
0.00
0 Broker 6M Target downgrade
Broker 6M Target upgrade
0.00
0 Broker 6M Target upgrade
Momentum score
48.91
Technically Neutral
Valuation score
4.50
Expensive Valuation
Quality score
74.55
High Financial Strength
Peer Comparison
All values except ratios in INR(Crores)
| Stock Name | Current Price Rs | PE TTM Price To Earnings | Market Capitalization In Cr | Dividend Yield 1yr % | Net Profit Qtr Cr | Net Profit Annual Growth YoY % | Operating Revenues Qtr Cr | Revenue Growth Qtr YoY | Price To Book Value |
|---|---|---|---|---|---|---|---|---|---|
| AstraZeneca Pharma India Ltd. | 3624.4 | 111.51 | 9061 | 0.05 | 26.33 | 0 | 209.47 | 0.47 | 24.86 |
| Sun Pharmaceutical Industries Ltd. | 590.29 | 84.84 | 141630.67 | 0.67 | 1812.79 | 0 | 8553.12 | 5.29 | 2.88 |
| Divi's Laboratories Ltd. | 3506.7 | 52.92 | 93085.35 | 0.45 | 519.59 | 0 | 1749.3 | 21.01 | 12.73 |
| Dr. Reddy's Laboratories Ltd. | 5074.05 | 52.4 | 84330.71 | 0.49 | 771.8 | 0 | 4910.89 | 2.03 | 5.41 |
| Cipla Ltd. | 854.3 | 37.43 | 68886.48 | 0.46 | 665.43 | 0 | 5038.29 | 14.61 | 4.29 |
| Aurobindo Pharma Ltd. | 1009.8 | 18.82 | 59164.18 | 0.42 | 806.23 | 0 | 6483.44 | 15.76 | 3.51 |
| Lupin Ltd. | 1096 | -389.78 | 49676.2 | 0.54 | 211.02 | 0 | 3835 | -12.04 | 3.94 |
| Cadila Healthcare Ltd. | 470 | 28.46 | 48128 | 0.74 | 473.4 | 0 | 3820 | 13.46 | 4.11 |